Tom Willis, PhD
Dr. Willis previously oversaw the product development and clinical validation of Adaptive’s diagnostic products. He previously served as the CEO and Co-founder of Sequenta, Inc. (acquired by Adaptive in 2015). Prior to Adaptive, Dr. Willis co-founded ParAllele BioScience (acquired by Affymetrix in 2005). He also co-invented Molecular Inversion Probe technology for high throughput genotyping, while at the Stanford Genome Technology Center. Dr. Willis received his Ph.D. in physics from Stanford University.